A graphical overview of in vitro sensitivity versus the resistance of FLT3 inhibitors (green—sensitive; orange—intermediate; red—resistant) towards distinct subtypes of activating FLT3 mutations, including compound mutations of FLT3 (ITD plus TKD) [61,62,63,64,65,66,67,68,69].